Bardoxolone Methyl

For research use only. Not for use in humans.

目录号:S8078 别名: RTA 402, TP-155, NSC 713200, CDDO Methyl Ester, CDDO-Me 中文名称:甲基巴多索隆

Bardoxolone Methyl Chemical Structure

CAS No. 218600-53-4

Bardoxolone Methyl (RTA 402, TP-155, NSC 713200, CDDO Methyl Ester, CDDO-Me) 是一种IKK抑制剂,具有强的促凋亡和抗炎活性。同时还是有效的Nrf2激活剂和NF-κB抑制剂。Bardoxolone Methyl 可抑制铁死亡。Bardoxolone Methyl 在癌细胞中可诱导凋亡和自噬。

规格 价格 库存 购买数量  
RMB 814.73 现货
RMB 4656.69 现货
有超大折扣

今日订购,明日送达,全国免运费!

全国免费电话:400-668-6834   |   Email:info@selleck.cn

客户使用Selleck生产的Bardoxolone Methyl发表文献17篇:

客户使用该产品的3个实验数据:

  • Renal Nrf2 activity was shown in RTA402-treated acFSGS (RTA402 + acFSGS) mice as early as day 7 (RTA402 + acFSGS) and persisted to day 28, compared to vehicle + acFSGS mice. Kidney in situ ROS production demonstrated by DHE detection.

    Free Radic Biol Med, 2014, 73:260-9 . Bardoxolone Methyl purchased from Selleck.

  • KG-1a cells were treated with Bar (0.5 µM) or a vehicle for 48 h and Annexin V/PI staining was detected after 48 h by flow cytometry.

    Oncol Rep, 2017, 38(3):1517-1524. Bardoxolone Methyl purchased from Selleck.

  • Cells were exposed to increasing concentrations of Bardoxolone methyl (BM; 0–1000 nM) and AR protein levels were measured. Top panels show representative immunoblots depicting AR-FL, AR-V7 and GAPDH levels. Bottom panels show fold change in AR proteins, normalized to GAPDH levels.

    Oncol Rep, 2017, 38(5):2774-2786. Bardoxolone Methyl purchased from Selleck.

产品安全说明书

IκB/IKK抑制剂选择性比较

生物活性

产品描述 Bardoxolone Methyl (RTA 402, TP-155, NSC 713200, CDDO Methyl Ester, CDDO-Me) 是一种IKK抑制剂,具有强的促凋亡和抗炎活性。同时还是有效的Nrf2激活剂和NF-κB抑制剂。Bardoxolone Methyl 可抑制铁死亡。Bardoxolone Methyl 在癌细胞中可诱导凋亡和自噬。
特性 Bardoxolone Methyl是一种口服有效的抗炎症调节剂,唯一用于临床实体瘤,2型糖尿病和慢性肾脏疾病的IKKβ抑制剂。
靶点
IKK [3]
(Cell-free assay)
Ferroptosis [7]
()
Nrf2 [6]
()
NF-κB [6]
()
体外研究

Bardoxolone Methyl作用于小鼠巨噬细胞,对interferon-Ƴ诱导的一氧化氮的产生具有强效的抑制活性,其IC50 为0.1 nM 。[1] Bardoxolone Methyl降低白血病HL-60,KG-1和NB4细胞的生存能力,其IC50分别为 0.4,0.4,和0.27μM。 CDDO-ME诱导促凋亡Bax蛋白表达,抑制ERK1 / 2的活化,并且它抑制Bcl-2的磷酸化,这有助于诱导细胞凋亡。[2] Bardoxolone Methyl可有效地抑制(IL)-1beta, phorbol ester, okadaic acid, hydrogen peroxide, lipopolysaccharide, 和cigarette smoke激活的组成型和可诱导的NF-κB的肿瘤坏死因子。[3]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
MCF-7 MXfGeY5kfGmxbjDhd5NigQ>? MUPJcohq[mm2b4L5JINwdmOnboTyZZRqd25iYXfhbY5{fCCycn;sbYZmemG2aX;uJI9nKE2FRj23JEhGWiCSb4PpeIl3\SliYoLlZZN1KGOjbnPldkBk\WyuczygTWM2OD1yLkC1{txO NEG5VW49[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zNUO2PVM6Pid-MUWzOlk{QTZ:L3G+
BMDM NWrtWnRCS3m2b4TvfIlkcXS7IHHzd4F6 M1rCWlI1KGi{cx?= MUPDfZRwfG:6aXPpeJkh[WejaX7zeEBEPTeETD:2JI1wfXOnIFLNSG0h[2WubIOgZZN{\XO|ZXSgZZMhVESKIILlcIVie2ViYX\0[ZIhOjRiaILzMEBOVlSGPUCuOe69VQ>? NInveVk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkWzN|c6OCd-MkK1N|M4QTB:L3G+
BMDM MmLKRY51cWmwZnzhcY1ifG:{eTDhd5NigQ>? MX2wMlUhfU1? MWOxJIhz MXLBcpRqcW6obHHtcYF1d3K7IHHjeIl3cXS7IHnuJGM2P0KOL{[gcY92e2ViQl3EUUBk\WyuczDhd5Nme3OnZDDhd{BqdmirYnn0bY9vKG:oIFzQV{1{fGmvdXzheIVlKFSQRnHsdIhiKHC{b3T1Z5Rqd25iYYSgNE42KHWPIIDy[ZRz\WG2ZXSg[o9zKDFiaIKgZoVnd3KnIFzQV{BkcGGubHXu[4Uh[W[2ZYKgPEB1dyB{NDDodpMh[nliaX3teY5w[XO|YYm= NEn2NoQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkWzN|c6OCd-MkK1N|M4QTB:L3G+
PANC1343 NWX6dohlSW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= NIm3WJA{ODBidH:gNVAxOCCwTR?= NE\GflE4OiCqcoO= MWjBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IH3veZNmKFCDTlOxN|Q{KGOnbHzzJIF1KDNyMDD0c{AyODByIH7NJIFnfGW{IEeyJIhzeyCkeTDNWHQh[XO|YYm= M4S2WVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2M{i4PFA3Lz5{NEO4PFgxPjxxYU6=
RAW264.7 MnTXRY51cW:6aXThcpQh[XO|YYm= M2nhSVExOCCwTR?= MlezNVghcHK| Mn36RY51cW:6aXThcpQh[WO2aY\peJkhcW5ibX;1d4UhWkGZMk[0Mlch[2WubIOgZZN{\XO|ZXSgZZMhcW6qaXLpeIlwdiCxZjD0RmhRNWmwZIXj[YQhWk:VIIDyc4R2[3Srb36gZZQhOTByIH7NJJBz\XS{ZXH0[YQh\m:{IEG4JIhzeyCkZX\vdoUh[2ijbHzlcodmKG2nYYP1doVlKGGodHXyJFE2KG2rboOgZpkhUDKGQ1\BMYJie2WmIH\sc5ch[3m2b33leJJ6 MWi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDN6OEiwOkc,OjR|OEi4NFY9N2F-
HepG2 MmntR5l1d3SxeHnjbZR6KGG|c3H5 M4\vcVQ5KGi{cx?= NEPuVnlEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBJ\XCJMjDj[YxteyCjZoTldkA1QCCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwQVQvQToQvF2= MWS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDZ6NUW0OUc,OjR4OEW1OFU9N2F-
B16F10 NWPHcIprS3m2b4TvfIlkcXS7IHHzd4F6 NGfkfW01QCCqcoO= NV7QcW5GS3m2b4TvfIlkcXS7IHHnZYlve3RibX;1d4UhSjF4RkGwJINmdGy|IHHmeIVzKDR6IHjyd{BjgSCPVGSgZZN{[XluIFnDOVA:PS56Nd88US=> M1XOUlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2Nki1OVQ2Lz5{NE[4OVU1PTxxYU6=
CCD-841-CoN M37vZmFvfGmycn;sbYZmemG2aY\lJIF{e2G7 M{\ydlczKGi{cx?= NIPCT|FCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFPDSE05PDFvQ3;OJINmdGy|IHHzd4V{e2WmIHHzJIlvcGmkaYTpc44hd2ZiY3XscEBxem:uaX\ldoF1cW:wIHHmeIVzKDd{IHjyd{BjgSCPVGSgZZN{[XluIFnDOVA:OC5|MUdOwG0> NU\kUodxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW2O|UyPDRpPkK1Olc2OTR2PD;hQi=>
HCT8 MVrBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? NEXX[XA4OiCqcoO= NVXocIFySW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEA2NU[XIILld4l{fGGwdDDoeY1idiCKQ2S4JINmdGy|IHHzd4V{e2WmIHHzJIlvcGmkaYTpc44hd2ZiY3XscEBxem:uaX\ldoF1cW:wIHHmeIVzKDd{IHjyd{BjgSCPVGSgZZN{[XluIFnDOVA:OC5|NkROwG0> M2LNelxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3Nke1NVQ1Lz5{NU[3OVE1PDxxYU6=
HCT8 NIrUb5FCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= M4Xo[FczKGi{cx?= NHzaXoNCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFjDWFgh[2WubIOgZZN{\XO|ZXSgZZMhcW6qaXLpeIlwdiCxZjDj[YxtKHC{b3zp[oVz[XSrb36gZYZ1\XJiN{KgbJJ{KGK7IF3UWEBie3OjeTygTWM2OD1yLkO5Pe69VQ>? MkjBQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV4N{WxOFQoRjJ3Nke1NVQ1RC:jPh?=
HCT8 MV\GeY5kfGmxbjDhd5NigQ>? MXixJJVO NET2S|gzPCCqcoO= Mki4TY5pcWKrdHnvckBw\iCKSV[tNYFteGijIIDyc5RmcW5iZYjwdoV{e2mxbjDpckBpfW2jbjDIR3Q5KGOnbHzzJIF1KDFidV2gbY5kfWKjdHXkJIZweiB{NDDodpMh[nliV3XzeIVzdiCkbH;0eIlv\yCvZYToc4Q> NIHJfWU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NU[3OVE1PCd-MkW2O|UyPDR:L3G+
HCT8 MlnqSpVv[3Srb36gZZN{[Xl? MYOxJJVO MUKyOEBpenN? NYjTN5I2UW6qaXLpeIlwdiCxZjDITWYuOWGucHjhJJBzd3SnaX6g[ZhxemW|c3nvckBqdiCIVT3y[ZNqe3SjboSgbJVu[W5iSFPUPEBk\WyuczDheEAyKHWPIHnuZ5Vj[XSnZDDmc5IhOjRiaILzJIJ6KFenc4Tldo4h[myxdITpcochdWW2aH;k M3jPPVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3Nke1NVQ1Lz5{NU[3OVE1PDxxYU6=
HCT8 M1HQUmZ2dmO2aX;uJIF{e2G7 MYWxJJVO NWLsfo1IOjRiaILz MUjJcohq[mm2aX;uJI9nKFOWQWSzJJBzd3SnaX6gdIhwe3Cqb4L5cIF1cW:wIHnuJIh2dWGwIFjDWFgh[2WubIOgZZQhOSC3TTDpcoN2[mG2ZXSg[o9zKDJ2IHjyd{BjgSCZZYP0[ZJvKGKub4T0bY5oKG2ndHjv[C=> M4W2cFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3Nke1NVQ1Lz5{NU[3OVE1PDxxYU6=
HCT8 NYf3XIVyTnWwY4Tpc44h[XO|YYm= MYexJJVO MkT1NlQhcHK| MXLJcohq[mm2aX;uJI9nKFOWQWSzJJBzd3SnaX6gdIhwe3Cqb4L5cIF1cW:wIHnuJGZWNXKnc3nzeIFvfCCqdX3hckBJS1R6IHPlcIx{KGG2IEGgeW0hcW6ldXLheIVlKG[xcjCyOEBpenNiYomgW4V{fGW{bjDicI91fGmwZzDt[ZRpd2R? M2fmZ|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3Nke1NVQ1Lz5{NU[3OVE1PDxxYU6=
HCT8 MXrGeY5kfGmxbjDhd5NigQ>? M3rvVVEhfU1? MUiyOEBpenN? M{\kXWlvcGmkaYTpc44hd2ZiQVvUJJBzd3SnaX6gdIhwe3Cqb4L5cIF1cW:wIHnuJIh2dWGwIFjDWFgh[2WubIOgZZQhOSC3TTDpcoN2[mG2ZXSg[o9zKDJ2IHjyd{BjgSCZZYP0[ZJvKGKub4T0bY5oKG2ndHjv[C=> MXe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTZ5NUG0OEc,OjV4N{WxOFQ9N2F-
HCT8 NGXsPWZHfW6ldHnvckBie3OjeR?= NFfONXQyKHWP NYCzVYtuOjRiaILz M37XWGlvcGmkaYTpc44hd2ZiQVvUJJBzd3SnaX6gdIhwe3Cqb4L5cIF1cW:wIHnuJGZWNXKnc3nzeIFvfCCqdX3hckBJS1R6IHPlcIx{KGG2IEGgeW0hcW6ldXLheIVlKG[xcjCyOEBpenNiYomgW4V{fGW{bjDicI91fGmwZzDt[ZRpd2R? MWC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTZ5NUG0OEc,OjV4N{WxOFQ9N2F-
HCT8 Mor0SpVv[3Srb36gZZN{[Xl? M2LYe|EhfU1? MX6yOEBpenN? M1PxbGlvcGmkaYTpc44hd2ZiRWLLJJBzd3SnaX6gdIhwe3Cqb4L5cIF1cW:wIHnuJIh2dWGwIFjDWFgh[2WubIOgZZQhOSC3TTDpcoN2[mG2ZXSg[o9zKDJ2IHjyd{BjgSCZZYP0[ZJvKGKub4T0bY5oKG2ndHjv[C=> M2HpZlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3Nke1NVQ1Lz5{NU[3OVE1PDxxYU6=
HCT8 MkHnSpVv[3Srb36gZZN{[Xl? NGCwNHoyKHWP M2jEclI1KGi{cx?= NGDocFJKdmirYnn0bY9vKG:oIFXST{Bxem:2ZXnuJJBpd3OyaH;yfYxifGmxbjDpckBHXS2{ZYPpd5RidnRiaIXtZY4hUEOWODDj[YxteyCjdDCxJJVOKGmwY4XiZZRm\CCob4KgNlQhcHK|IHL5JHdme3Sncn6gZoxwfHSrbnegcYV1cG:m M2[zUlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3Nke1NVQ1Lz5{NU[3OVE1PDxxYU6=
HCT8 MlKwRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? NVuwZohSOSC3TR?= Mn;BO|IhcHK| Ml\qRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCKQ2S4JINmdGy|IHHzd4V{e2WmIHHzJIlvcGmkaYTpc44hd2ZiY3XscEBxem:uaX\ldoF1cW:wIHH0JFEhfU1iYX\0[ZIhPzJiaILzJIJ6KE2WVDDhd5NigQ>? MkHMQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV4N{WxOFQoRjJ3Nke1NVQ1RC:jPh?=
HCT8 MknHRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? MVexJJVO M37ue|czKGi{cx?= MonsRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDC1MWZWKHKnc3nzeIFvfCCqdX3hckBJS1R6IHPlcIx{KGG|c3Xzd4VlKGG|IHnubIljcXSrb36gc4Yh[2WubDDwdo9tcW[ncnH0bY9vKGG2IEGgeW0h[W[2ZYKgO|IhcHK|IHL5JG1VXCCjc4PhfS=> M17KU|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3Nke1NVQ1Lz5{NU[3OVE1PDxxYU6=
BEAS2B M17sTWZ2dmO2aX;uJIF{e2G7 MYGxNEB2VQ>? NH[zV2g3KGi{cx?= Ml;YRYN1cX[jdHnvckBw\iCQcn[yJIlvKGi3bXHuJGJGSVN{QjDj[YxteyCjc4Pld5Nm\CCjczDpcoNz\WG|ZTDpckBJVzFiZ3Xu[UBmgHC{ZYPzbY9vKGG2IEGwJJVOKGmwY4XiZZRm\CCob4KgOkBpenNiYomgdXBEWiCvZYToc4Q> NUDOW3RQRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMk[yO|gxOjhpPkK2Nlc5ODJ6PD;hQi=>
H42E NV3QcHR1TnWwY4Tpc44h[XO|YYm= M37O[|I1KGi{cx?= M2W3PWlv\HWldHnvckBw\iCQUl[yJIFkfGm4YYTpc44hcW5icnH0JGg1OkViY3XscJMh\XiycnXzd4lv\yCDUlW4UEBie3Onc4Pl[EBieyC{ZYDvdpRmeiC2cnHud4dmdmViYXP0bZZqfHliYX\0[ZIhOjRiaILzJIJ6KGy3bXnu[ZNk\W6lZTDhd5NigSxiQ1S9NE4xODB3zszN M4e2d|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ4OUC4NVc{Lz5{NkmwPFE4OzxxYU6=
H42E NUDFTZBjS3m2b4TvfIlkcXS7IHHzd4F6 NXz0V|NVOjRiaILz NHHkWINEgXSxdH;4bYNqfHliYXfhbY5{fCC{YYSgTFQzTSClZXzsd{BmgHC{ZYPzbY5oKEGURUjMJIF{e2W|c3XkJIF{KGOnbHz1cIFzKEGWUDDs[ZZmdCCjZoTldkAzPCCqcoOgZpkhS2WubITpeIVzNUeubzDseY1qdmW|Y3XueEBk\WyuII\pZYJqdGm2eTDhd5NigSxiSVO1NF0yNjUQvF2= NYLxbFV{RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMk[5NFgyPzNpPkK2PVA5OTd|PD;hQi=>
H42E MoPxSpVv[3Srb36gZZN{[Xl? MX[wMlAyKHSxIEOwJI5O MUCxJIhz MWTTeIFjcWyrenH0bY9vKG:oIF7SSlIhcW5icnH0JGg1OkViY3XscJMh\XiycnXzd4lv\yCDUlW4UEBifCByLkCxJJRwKDNyIH7NJIFnfGW{IEGgbJIh[nliV3XzeIVzdiCkbH;0JIFv[Wy7c3nz M1zPN|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ4OUC4NVc{Lz5{NkmwPFE4OzxxYU6=
NHBE NGPad5NEgXSxcILveIVkfGm4ZTDhd5NigQ>? Ml6yNE4xODFidH:gNE4yKHWP MYmxPEBpenN? MV\DfZRweHKxdHXjeIl3\SCjY4Tpeol1gSCrbjDOTGJGKGOnbHzzJIF{e2W|c3XkJIF{KGmwaHnibZRqd25ib3[geGJJWC2rbnT1Z4VlKEeVSDDk[ZBt\XSrb36gZZQhOC5yMEGgeI8hOC5zIIXNJJBz\WmwY4XiZZRm\CCob4KgNVghcHK|IH\vcIxwf2WmIHL5JJRDUFBiYXTkbZRqd25iZn;yJFQhcHK|IHL5JJRpcW:|dHHyJIR6\SCkYYPl[EBndHWxcnXzZ4Vv[2ViYYPzZZk> MYi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPzB|MU[3NEc,OjdyM{G2O|A9N2F-
NHBE M4HGOmZ2dmO2aX;uJIF{e2G7 NG\tVJIyODBibl2= MXKyOEBpenN? NFfmOINKdmirYnn0bY9vKG:oIFvFRXAyN06URkKgbY51\XKjY4Tpc44hcW5iTljCSUBk\WyuczDhd5Nme3OnZDDhd{BqdmO{ZXHz[UBqdiCJQ1zNJI1TVkFiZYjwdoV{e2mxbjDheEAyODBibl2gbY5kfWKjdHXkJIZweiB{NDDodpMhcW5icILld4Vv[2Vib3[gco9vKHSjcnfleIlv\yC|aWLORUBjgSCzUmStVGNTKG2ndHjv[C=> MYS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPzB|MU[3NEc,OjdyM{G2O|A9N2F-
NHBE M3vlTmZ2dmO2aX;uJIF{e2G7 Ml2yNVAxKG6P MlG1NlQhcHK| Mk\HTY5pcWKrdHnvckBw\iCNRVHQNU9PWkZ{IHnueIVz[WO2aX;uJIlvKE6KQlWgZ4VtdHNiYYPz[ZN{\WRiYYOgbY5kemWjc3WgbY4hVlGRMTDtVm5CKGW6cILld5Nqd25iYYSgNVAxKG6PIHnuZ5Vj[XSnZDDmc5IhOjRiaILzJIlvKHC{ZYPlcoNmKG:oIH7vckB1[XKpZYTpcoche2mUTlGgZpkheVKWLWDDVkBu\XSqb3S= NHjGUpM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{N{CzNVY4OCd-MkewN|E3PzB:L3G+
NHBE NGm0c3BHfW6ldHnvckBie3OjeR?= NWPybGl5OTByIH7N M17QNlQ5KGi{cx?= NWD2NWpjUW6qaXLpeIlwdiCxZjDLSWFROS:QUl[yJIlvfGW{YXP0bY9vKGmwIF7IRmUh[2WubIOgZZN{\XO|ZXSgZZMhcW6mdXP0bY9vKG:oIF7RU|Ehe3CnY3nmbYMh[WO2aY\peJkh[XRiMUCwJI5OKGmwY4XiZZRm\CCob4KgOFghcHK|IHnuJJBz\XOnbnPlJI9nKG6xbjD0ZZJo\XSrbnegd4lTVkFiYomgUXRVKHKnZIXjeIlwdiCjc4PhfS=> NF7CXJg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{N{CzNVY4OCd-MkewN|E3PzB:L3G+
HaCaT-ARE-luc NVrQNnBSTnWwY4Tpc44h[XO|YYm= MWO2JIhzew>? MYPBZ5RqfmG2aX;uJI9nKE6{ZkKgLJVvc26xd36gc5Jq\2mwKTDlfJBz\XO|ZXSgbY4hcHWvYX6gTIFE[VRvQWLFMYx2[yClZXzsd{Bi\nSncjC2JIhzeyCkeTDseYNq\mW{YYPlJJJmeG:{dHXyJIdmdmViYYPzZZktKEWFNUC9NE4xPs7:TR?= M2fBWVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6N{WzNlk1Lz5{OEe1N|I6PDxxYU6=
NIH/3T3 MUjGeY5kfGmxbjDhd5NigQ>? M3zOe|YhcHK| NG[5c|hKdmirYnn0bY9vKG:oIGTOSk1idHCqYTDzeIlufWyjdHXkJG5HNWujcIDhRkApfW6tbn;3ckBwemmpaX6pJIV5eHKnc4Pl[EBqdiCvb4Xz[UBPUUhxM2SzJINmdGy|IHHmeIVzKDZiaILzJIJ6KGy3Y3nm[ZJie2VicnXwc5J1\XJiZ3Xu[UBie3OjeTygTWM2OD1zLkNOwG0> MYq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDd3M{K5OEc,Ojh5NUOyPVQ9N2F-
HeLa MX7GeY5kfGmxbjDhd5NigQ>? Mk\0OkBpenN? MmfWTY5pcWKrdHnvckBw\iCLRl6t[4FudWFic4TpcZVt[XSnZDDTWGFVOyBqdX7rco94diCxcnnnbY4qKGW6cILld5Nm\CCrbjDoeY1idiCKZVzhJINmdGy|IHHmeIVzKDZiaILzJIJ6KGy3Y3nm[ZJie2VicnXwc5J1\XJiZ3Xu[UBie3OjeTygTWM2OD1{LkO4{txO NX64XFBsRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMki3OVMzQTRpPkK4O|U{Ojl2PD;hQi=>
RAW264.7 NYPlc49rSW62aT3pcoZt[W2vYYTvdpkh[XO|YYm= MnrPRY51cS2rbn\sZY1u[XSxcomgZYN1cX[rdImgbY4hdW:3c3WgVmFYOjZ2LkegZ4VtdHNiYYPz[ZN{\WRiYYOgbY5pcWKrdHnvckBw\iCwaYTybYMhd3irZHWgdJJw\HWldHnvckwhUUN3ME20{txO MmTLQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh5NUS0O|AoRjJ6N{W0OFcxRC:jPh?=
HEK293 NV\xbpFJS3m2b4TvfIlkcXS7IHHzd4F6 NED6VWYzPCCqcoO= NFn6NoFEgXSxdH;4bYNqfHliYXfhbY5{fCCKRVuyPVMh[2WubIOgZZN{\XO|ZXSgZZMhemWmdXP0bY9vKGmwIHPlcIwhfmmjYnnsbZR6KGGodHXyJFI1KGi{czDifUBOXFRiYYPzZZktKEmFNUC9Nk4z|ryP Moi5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh7OUSyPFYoRjJ6OUm0Nlg3RC:jPh?=
H9c2 NHWzNnVEgXSxdH;4bYNqfHliYYPzZZk> Mn[5NlQhcHK| M2fVPWN6fG:2b4jpZ4l1gSCjZ3HpcpN1KHKjdDDIPYMzKGOnbHzzJIF{e2W|c3XkJIF{KHKnZIXjeIlwdiCrbjDj[YxtKH[rYXLpcIl1gSCjZoTldkAzPCCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwQVUvOs7:TR?= M4i1eFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6OUm0Nlg3Lz5{OEm5OFI5PjxxYU6=
HEK293 MWPGeY5kfGmxbjDhd5NigQ>? NIDjNYMzODBidH:gNVAxOCCwTR?= NHXqfGUzPCCqcoO= MYLJcohq[mm2aX;uJI9nKEmNS3LleIEhMHWwa37ve44hd3KrZ3nuLUB1emGwc3\lZ5Rm\CCrbjDISWszQTNiY3XscJMh[XO|ZYPz[YQh[XNiVF7GZYxxcGFvaX7keYNm\CCQRnvhdJBiSiCjY4TpeoF1cW:wIHH0JFIxOCC2bzCxNFAxKG6PIHHkcYlvcXO2ZYLl[EA3KGi{czDh[pRmeiCWTl\hcJBp[SC|dHnteYxifGmxbjDt[YF{fXKnZDDmc5IhOjRiaILzJIJ6KE6Ia3HwdIFDNWS{aY\lckBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWgZZN{[Xl? M2DYU|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6OUm0Nlg3Lz5{OEm5OFI5PjxxYU6=
HEK293 MX\GeY5kfGmxbjDhd5NigQ>? Mn31NlAxKHSxIEGwNFAhdk1? NYjoW2JJOjRiaILz NWnib3prUW6qaXLpeIlwdiCxZjDJT2tj\XSjIDj1cotvd3ewIH;ybYdqdilidILhcpNn\WO2ZXSgbY4hUEWNMkmzJINmdGy|IHHzd4V{e2WmIHHzJJJm\HWldHnvckBqdiCWTl\hcJBp[S2rbnT1Z4VlKHWycnXneYxifGmxbjDv[kBqVk:VIH3SUmEh\XiycnXzd4lwdiCjdDCyNFAhfG9iMUCwNEBvVSCjZH3pcol{fGW{ZXSgOkBpenNiYX\0[ZIhXE6IYXzwbIEhe3SrbYXsZZRqd25ibXXhd5Vz\WRiZn;yJFI1KGi{czDifUByfWGwdHn0ZZRqfmViUmStVGNTKGGw M1vsVVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6OUm0Nlg3Lz5{OEm5OFI5PjxxYU6=
HEK293 MmTSSpVv[3Srb36gZZN{[Xl? NXfkbmJxOjByIITvJFExODBibl2= M13QbFI1KGi{cx?= Ml3RTY5pcWKrdHnvckBw\iCLS1vi[ZRiKCi3bnvuc5dvKG:{aXfpckkhfHKjboPm[YN1\WRiaX6gTGVMOjl|IHPlcIx{KGG|c3Xzd4VlKGG|IILl[JVkfGmxbjDpckBVVk[jbIDoZU1qdmS3Y3XkJJVxemWpdXzheIlwdiCxZjDDU3gzKG2UTlGg[ZhxemW|c3nvckBifCB{MECgeI8hOTByMDDuUUBi\G2rbnnzeIVz\WRiNjDodpMh[W[2ZYKgWG5H[WyyaHGgd5RqdXWuYYTpc44hdWWjc4Xy[YQh\m:{IEK0JIhzeyCkeTDxeYFvfGm2YYTpeoUhWlRvUFPSJIFv MUO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDl7NEK4Okc,Ojh7OUSyPFY9N2F-
HEK293 MnexSpVv[3Srb36gZZN{[Xl? NUD3OZF2OjByIITvJFExODBibl2= NXLCdXBYOjRiaILz NWfOboVKUW6qaXLpeIlwdiCxZjDJT2tj\XSjIDj1cotvd3ewIH;ybYdqdilidILhcpNn\WO2ZXSgbY4hUEWNMkmzJINmdGy|IHHzd4V{e2WmIHHzJJJm\HWldHnvckBqdiCWTl\hcJBp[S2rbnT1Z4VlKHWycnXneYxifGmxbjDv[kBOS1BzIH3SUmEh\XiycnXzd4lwdiCjdDCyNFAhfG9iMUCwNEBvVSCjZH3pcol{fGW{ZXSgOkBpenNiYX\0[ZIhXE6IYXzwbIEhe3SrbYXsZZRqd25ibXXhd5Vz\WRiZn;yJFI1KGi{czDifUByfWGwdHn0ZZRqfmViUmStVGNTKGGw NVHxUJI1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMki5PVQzQDZpPkK4PVk1Ojh4PD;hQi=>
intraglomerular mesangial cells NWm0O4l2TnWwY4Tpc44h[XO|YYm= MXOwMlY2KG2pL3vn NYTWeo5mOTJid3Xlb5M> NIGxe2pT\W6xcILveIVkfGm4ZTDhZ5Rqfmm2eTDpckBl[i:mYjDtc5V{\SCjc4Pld5Nm\CCjczDpcoNz\WG|ZTDpckBvfW2kZYKgc4YhcW62cnHncI9u\XK3bHHyJI1me2GwZ3nhcEBk\WyuczDheEAxNjZ3IH3nM4toNCCrcDDh[I1qdmm|dHXy[YQhfHKrY3WgdIVzKHenZXug[o9zKDF{IHPvcpNm[3W2aY\lJJdm\Wu|IH3lZZN2emWmIHH0JFEyKHenZXvzJJBwe3RiZH;z[UBjgSCKL1Wtd5RicW6rbnegZoF{\WRibXnjdo9{[2:yaXOgZY5idHm|aYO= M3\jT|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6OUm0Nlg3Lz5{OEm5OFI5PjxxYU6=
HEK293 NYr5cYV2TnWwY4Tpc44h[XO|YYm= NVPiOVVlOjByIITvJFExODBibl2= MkXHNlQhcHK| M{Sxe2lvcGmkaYTpc44hd2ZiSVvLZoV1[SBqdX7rco94diCxcnnnbY4qKHS{YX7z[oVkfGWmIHnuJGhGUzJ7MzDj[YxteyCjc4Pld5Nm\CCjczDy[YR2[3Srb36gbY4hXE6IYXzwbIEucW6mdXPl[EB2eHKnZ4XsZZRqd25ib3[gR29ZOiCycn;0[YlvKGW6cILld5Nqd25iYYSgNlAxKHSxIEGwNFAhdk1iYXTtbY5qe3SncnXkJFYhcHK|IHHmeIVzKFSQRnHsdIhiKHO2aX31cIF1cW:wIH3lZZN2emWmIH\vdkAzPCCqcoOgZpkhX2W|dHXyckBjdG:2IH3leIhw\A>? M1T4UlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6OUm0Nlg3Lz5{OEm5OFI5PjxxYU6=
HEK293 NHvkNWtHfW6ldHnvckBie3OjeR?= MYKyNFAhfG9iMUCwNEBvVQ>? NVr4VG5QOjRiaILz NYrGeW1EUW6qaXLpeIlwdiCxZjDJT2tj\XSjIDj1cotvd3ewIH;ybYdqdilidILhcpNn\WO2ZXSgbY4hUEWNMkmzJINmdGy|IHHzd4V{e2WmIHHzJJJm\HWldHnvckBqdiCWTl\hcJBp[S2rbnT1Z4VlKHWycnXneYxifGmxbjDv[kBqVk:VIIDyc5RmcW5iZYjwdoV{e2mxbjDheEAzODBidH:gNVAxOCCwTTDh[I1qdmm|dHXy[YQhPiCqcoOgZYZ1\XJiVF7GZYxxcGFic4TpcZVt[XSrb36gcYVie3W{ZXSg[o9zKDJ2IHjyd{BjgSCZZYP0[ZJvKGKub4SgcYV1cG:m M4fGO|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6OUm0Nlg3Lz5{OEm5OFI5PjxxYU6=
HEK293 NEjWXm1HfW6ldHnvckBie3OjeR?= M4f4clIxOCC2bzCxNFAxKG6P MV2yOEBpenN? NXHZW2ViUW6qaXLpeIlwdiCxZjDJT2tj\XSjIDj1cotvd3ewIH;ybYdqdilidILhcpNn\WO2ZXSgbY4hUEWNMkmzJINmdGy|IHHzd4V{e2WmIHHzJI1qfGmpYYTpc44hd2ZiVF7GZYxxcGFvaX7keYNm\CCrbnPy[YF{\SCrbjDyZZRqdyCxZjDueYNt\WG{IITvJIN6fG:|b3zpZ{BxPjViYYSgNlAxKHSxIEGwNFAhdk1iYXTtbY5qe3SncnXkJFYhcHK|IHHmeIVzKFSQRnHsdIhiKHO2aX31cIF1cW:wIH3lZZN2emWmIH\vdkAzPCCqcoOgZpkhX2W|dHXyckBjdG:2 MkH6QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh7OUSyPFYoRjJ6OUm0Nlg3RC:jPh?=
HEK293 M1HQc2Z2dmO2aX;uJIF{e2G7 MkThNlAxKHSxIEGwNFAhdk1? NHSxcFIzPCCqcoO= MnntTY5pcWKrdHnvckBw\iCLS1vi[ZRiKCi3bnvuc5dvKG:{aXfpckkhfHKjboPm[YN1\WRiaX6gTGVMOjl|IHPlcIx{KGG|c3Xzd4VlKGG|IILl[JVkfGmxbjDpckBVVk[jbIDoZU1qdmS3Y3XkJJVxemWpdXzheIlwdiCxZjDNR3AyKHC{b4TlbY4h\XiycnXzd4lwdiCjdDCyNFAhfG9iMUCwNEBvVSCjZH3pcol{fGW{ZXSgOkBpenNiYX\0[ZIhXE6IYXzwbIEhe3SrbYXsZZRqd25ibXXhd5Vz\WRiZn;yJFI1KGi{czDifUBY\XO2ZYLuJIJtd3RibXX0bI9l NGH0PJg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OEm5OFI5Pid-Mki5PVQzQDZ:L3G+
HEK293 MY\GeY5kfGmxbjDhd5NigQ>? NXLoZ452OjByIITvJFExODBibl2= M3OzclQ5KGi{cx?= NYjQOlFSUW6qaXLpeIlwdiCxZjDL[YFxOS:Qcn[yJEh2dmuwb4fuJI9zcWerbjmgbY51\XKjY4Tpc44hfHKjboPm[YN1\WRiaX6gTGVMOjl|IHPlcIx{KGG|c3Xzd4VlKGG|IIXwdoVofWyjdHnvckBw\iCKTz2xJI1TVkFiZYjwdoV{e2mxbjDheEAzODBidH:gNVAxOCCwTTDh[pRmeiB2ODDodpMh[nlicYXhcpRqfGG2aY\lJHJVNVCFUjDhcoFtgXOrcx?= MX68ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDl7NEK4Okc,Ojh7OUSyPFY9N2F-
HEK293 MmPBSpVv[3Srb36gZZN{[Xl? NYHqPJBQOjByIITvJFExODBibl2= NVvyTGhvPDhiaILz NHT1dYtKdmirYnn0bY9vKG:oIFvlZZAyN06{ZkKgLJVvc26xd36gc5Jq\2mwKTDpcpRmemGldHnvckB1emGwc3\lZ5Rm\CCrbjDISWszQTNiY3XscJMh[XO|ZYPz[YQh[XNidYDy[Yd2dGG2aX;uJI9nKE6TT{GgcXJPSSCneIDy[ZN{cW:wIHH0JFIxOCC2bzCxNFAxKG6PIHHmeIVzKDR6IHjyd{BjgSCzdXHueIl1[XSrdnWgVnQuWEOUIHHuZYx6e2m| M13wOlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6OUm0Nlg3Lz5{OEm5OFI5PjxxYU6=
HEK293 MlfxSpVv[3Srb36gZZN{[Xl? MU[yNFAhfG9iMUCwNEBvVQ>? NYrkeHRpPDhiaILz MonETY5pcWKrdHnvckBw\iCNZXHwNU9PemZ{IDj1cotvd3ewIH;ybYdqdiliaX70[ZJi[3Srb36geJJidnOoZXP0[YQhcW5iSFXLNlk{KGOnbHzzJIF{e2W|c3XkJIF{KGGldHn2ZZRqd25ib3[gUpJnOiCjdDCyNFAhfG9iMUCwNEBvVSCjZoTldkA1QCCqcoOgZpkhSVKHLXTybZZmdiCudXPp[oVz[XOnIILldI9zfGW{IHflcoUh[XO|YYm= NULRcIxURGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMki5PVQzQDZpPkK4PVk1Ojh4PD;hQi=>
HEK293 NWnyW5lzTnWwY4Tpc44h[XO|YYm= MWiyNFAhfG9iMUCwNEBvVQ>? M{nmcFQ5KGi{cx?= NHH6UnVKdmirYnn0bY9vKG:oIFvlZZAyN06{ZkKgLJVvc26xd36gc5Jq\2mwKTDpcpRmemGldHnvckB1emGwc3\lZ5Rm\CCrbjDISWszQTNiY3XscJMh[XO|ZYPz[YQh[XNiaX7jdoVie2ViaX6gcpVkdGWjcjD0c{BkgXSxc3;sbYMhVm[{MjDyZZRqdyCjdDCyNFAhfG9iMUCwNEBvVSCjZoTldkA1QCCqcoOgZpkhX2W|dHXyckBjdG:2IHHuZYx6e2m| MknkQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh7OUSyPFYoRjJ6OUm0Nlg3RC:jPh?=
HEK293 NXW5UZJ6TnWwY4Tpc44h[XO|YYm= MoK3NlAxKHSxIEGwNFAhdk1? NIPxbII1QCCqcoO= Mli4TY5pcWKrdHnvckBw\iCNZXHwNU9PemZ{IDj1cotvd3ewIH;ybYdqdiliaX70[ZJi[3Srb36geJJidnOoZXP0[YQhcW5iSFXLNlk{KGOnbHzzJIF{e2W|c3XkJIF{KGmwY4LlZZNmKGmwIHP5eI9{d2yrYzDIU{0yKGyndnXsd{BifCB{MECgeI8hOTByMDDuUUBi\nSncjC0PEBpenNiYomgW4V{fGW{bjDicI91KGGwYXz5d4l{ NVTKV2RSRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMki5PVQzQDZpPkK4PVk1Ojh4PD;hQi=>
HEK293 MmH1SpVv[3Srb36gZZN{[Xl? MmC3NlAxKHSxIEGwNFAhdk1? NVO2PWhrPDhiaILz MoPzTY5pcWKrdHnvckBw\iCNZXHwNU9PemZ{IDj1cotvd3ewIH;ybYdqdiliaX70[ZJi[3Srb36geJJidnOoZXP0[YQhcW5iSFXLNlk{KGOnbHzzJIF{e2W|c3XkJIF{KGmwY4LlZZNmKGmwIHP5eI9{d2yrYzDOVW8yKGyndnXsd{BifCB{MECgeI8hOTByMDDuUUBi\nSncjC0PEBpenNiYomgW4V{fGW{bjDicI91KGGwYXz5d4l{ MX28ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDl7NEK4Okc,Ojh7OUSyPFY9N2F-
A549/TR M{fTZWFvfGmycn;sbYZmemG2aY\lJIF{e2G7 NXm3UZh2PzJiaILz MWfBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEF3NEmvWHIh[2WubIOgZYZ1\XJiN{KgbJJ{KGK7IF3UWEBie3OjeTygTWM2OD1zLkewN:69VQ>? M1HzUlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NUCxPVQ4Lz5{OUWwNVk1PzxxYU6=
A549 M4H3SGFvfGmycn;sbYZmemG2aY\lJIF{e2G7 NVLaeHp6PzJiaILz M2f5cGFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iQUW0PUBk\WyuczDh[pRmeiB5MjDodpMh[nliTWTUJIF{e2G7LDDJR|UxRTJwMEe0{txO MXi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTVyMUm0O{c,Ojl3MEG5OFc9N2F-
A549/TR M{jIN2Z2dmO2aX;uJIF{e2G7 NIG1OG8zNjRidH:gPU43KHWP NUjsOHN6OjRiaILz MnXRTY5lfWO2aX;uJI9nKFKRUzDn[Y5memG2aX;uJIlvKGi3bXHuJGE2PDlxVGKgZ4VtdHNiYYSgNk41KHSxIEmuOkB2VSCjZoTldkAzPCCqcoOgZpkhTEOISD3ERUBlgWVvYnHz[YQh\myxdzDjfZRwdWW2cnnjJIFv[Wy7c3nz M2TQSFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NUCxPVQ4Lz5{OUWwNVk1PzxxYU6=
A549/TR M3rvdWZ2dmO2aX;uJIF{e2G7 MV:0MlghfU1? NEjOXHozPCCqcoO= MWLEc5dvemWpdXzheIlwdiCxZjDMc44h\XiycnXzd4lwdiCrbjDoeY1idiCDNUS5M3RTKGOnbHzzJIF1KDRwODD1UUBi\nSncjCyOEBpenNiYomgW4V{fGW{bjDicI91KGGwYXz5d4l{ MY[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTVyMUm0O{c,Ojl3MEG5OFc9N2F-
HCT116 MULBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? MVO3NkBpenN? M{XyPWFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iSFPUNVE3KGOnbHzzJIFnfGW{IEeyJIhzeyCkeTDTVmIh[XO|YYmsJGlEPTB;MD6wNFAzPc7:TR?= MmPoQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOzB2Mkm5OVMoRjNyNEK5PVU{RC:jPh?=
HT-29 MVjBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? MmDVO|IhcHK| M2XUW2FvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iSGStNlkh[2WubIOgZYZ1\XJiN{KgbJJ{KGK7IGPSRkBie3OjeTygTWM2OD1yLkK4{txO M3vOSFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzNyNEK5PVU{Lz5|MESyPVk2OzxxYU6=
HCT8 NUDtco1{SW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= MmLUO|IhcHK| M4XybGFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iSFPUPEBk\WyuczDh[pRmeiB5MjDodpMh[nliU2LCJIF{e2G7LDDJR|UxRTBwMkpOwG0> NX7adm5QRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxM{C0Nlk6PTNpPkOwOFI6QTV|PD;hQi=>
HCT116 MWTGeY5kfGmxbjDhd5NigQ>? MY[4JIhzew>? NYe3e4xuUW6qaXLpeIlwdiCxZjDCcYkyKHC{b4TlbY4h\XiycnXzd4lwdiCrbjDoeY1idiCKQ2SxNVYh[2WubIOgZYZ1\XJiODDodpMh[nliV3XzeIVzdiCkbH;0JIFv[Wy7c3nz MmDLQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOzB2Mkm5OVMoRjNyNEK5PVU{RC:jPh?=
BEAS2B MXjGeY5kfGmxbjDhd5NigQ>? NHm3TYs1QCCqcoO= M{CwSGFkfGm4YYTpc44hd2ZiS3XhdFEwS3WuMz;OdoYzKGmwIHj1cYFvKEKHQWOyRkBk\WyuczDhd5Nme3OnZDDhd{BqdmO{ZXHz[UBqdiCQUV:xJIxmfmWuczDt[YF{fXKnZDDh[pRmeiB2ODDodpMtKEWFNUC9NE4xODh5Md88US=> MnKxQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOzB4Mk[1OVUoRjNyNkK2OVU2RC:jPh?=
HepG2 MWHDfZRwfG:6aXPpeJkh[XO|YYm= MkS2OFghcHK| MWrDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDI[ZBIOiClZXzsd{Bie3Onc4Pl[EBieyC{ZXT1Z5Rqd25iaX6gZ4VtdCC4aXHibYxqfHliaX7jeYJifGWmIH\vdkA1QCCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwQVAvOjcQvF2= NYnS[5ZCRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxM{GwOVE1ODFpPkOxNFUyPDBzPD;hQi=>
MCF7 MYnDfZRwfG:6aXPpeJkh[XO|YYm= M2S1dVQ5KGi{cx?= MlPpR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gUWNHPyClZXzsd{Bie3Onc4Pl[EBieyC{ZXT1Z5Rqd25iaX6gZ4VtdCC4aXHibYxqfHliaX7jeYJifGWmIH\vdkA1QCCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwQVAvOzYQvF2= MmHBQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOzFyNUG0NFEoRjNzMEWxOFAyRC:jPh?=
A549 MUHDfZRwfG:6aXPpeJkh[XO|YYm= M3PkOlQ5KGi{cx?= MnLQR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gRVU1QSClZXzsd{Bie3Onc4Pl[EBieyC{ZXT1Z5Rqd25iaX6gZ4VtdCC4aXHibYxqfHliaX7jeYJifGWmIH\vdkA1QCCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwQVAvOzcQvF2= NHTCTog9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9|MUC1NVQxOSd-M{GwOVE1ODF:L3G+
A549 NUK4fopNSW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= M2nWWFQ5KGi{cx?= NFHDe5RCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFG1OFkh[2WubIOgZZN{\XO|ZXSgZZMhcW6qaXLpeIlwdiCxZjDj[YxtKGe{b4f0bEBqdmO3YnH0[YQh\m:{IES4JIhzeyCkeTDNWHQh[XO|YYmsJGlEPTB;MD61Nu69VQ>? MlnTQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOzF5MkWyPFgoRjNzN{K1Nlg5RC:jPh?=
HepG2 NF25U45CdnSrcILvcIln\XKjdHn2[UBie3OjeR?= NWTTZnRIPDhiaILz M{PSXGFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iSHXwS|Ih[2WubIOgZZN{\XO|ZXSgZZMhcW6qaXLpeIlwdiCxZjDj[YxtKGe{b4f0bEBqdmO3YnH0[YQh\m:{IES4JIhzeyCkeTDNWHQh[XO|YYmsJGlEPTB;MD61Nu69VQ>? NFvhNXE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9|MUeyOVI5QCd-M{G3NlUzQDh:L3G+
HOS Mo[xRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? MnHFOFghcHK| MoPERY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCKT2OgZ4VtdHNiYYPz[ZN{\WRiYYOgbY5pcWKrdHnvckBw\iClZXzsJIdzd3e2aDDpcoN2[mG2ZXSg[o9zKDR6IHjyd{BjgSCPVGSgZZN{[XluIFnDOVA:OC54Nt88US=> Mn\IQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOzF5MkWyPFgoRjNzN{K1Nlg5RC:jPh?=
MCF7 NX3CVnVSSW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= M1\4fVQ5KGi{cx?= M2L0fGFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iTVPGO{Bk\WyuczDhd5Nme3OnZDDhd{BqdmirYnn0bY9vKG:oIHPlcIwh\3Kxd4ToJIlv[3WkYYTl[EBnd3JiNEigbJJ{KGK7IF3UWEBie3OjeTygTWM2OD1yLki1{txO NELES|I9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9|MUeyOVI5QCd-M{G3NlUzQDh:L3G+
HEK293FT NWm5d2gxTnWwY4Tpc44h[XO|YYm= NWTZWpBWOjRiaILz MYHJcohq[mm2aX;uJI9nKG2xdYPlJGdQSVRiZYjwdoV{e2WmIHnuJGhGUzJ7M1\UJINmdGy|IHPvMYV5eHKnc4PpcocheHKnLYDyc4dpemWuaX6gZZN{\XO|ZXSgZZMhemWmdXP0bY9vKGmwIHfodoVtcW5ib3P0ZY5wgWyjdHnvckBqdmO3YnH0[YQh\m:{IEK0JIhzeyCkeTDFUGlUSSxiSVO1NF0xNjB|Nd88US=> M2LCXFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE4PjJ4MkGvK|5EcEWPQly8M4E,

... Click to View More Cell Line Experimental Data

Assay
Methods Test Index PMID
Western blot
p-IκBα / IκBα ; 

PubMed: 25897966     


HeLa cells were pre-treated with RTA 408 or bardoxolone methyl for 6 hours at the indicated concentrations followed by a five-minute treatment with TNFα. Protein levels of phospho-IκBα and total IκBα were evaluated by western blot. Actin was used as loading control. Data are representative of four experiments.

Bcl-xl / Bcl-2 / Bax / Cleaved caspase / Cytochrome C / PARP / Cleaved PARP ; 

PubMed: 25733817     


Representative blots of respective proteins measured to show the effect of CDDO-Me treatment on the expression levels of Bcl-xl, Bcl-2, Bax, PUMA, cytochrome c, cleaved caspase-3 (active), cleaved caspase-9 (active), PARP, and cleaved PARP in Ec109 and KYSE70 cells determined using Western blotting analysis. 

p-PI3K / PI3K / p-AMPK / AMPK / p-p38 MAPK / p38 MAPK / p-AKT / AKT / p-mTOR / mTOR; 

PubMed: 25733817     


Effects of CDDO-Me treatment on the expression levels of p-PI3K at Tyr458, PI3K, p-AMPK at Thr172, AMPK, p-p38 at Thr180, p38, p-Akt at Ser473, Akt, p-mTOR at Ser2448, mTOR, PTEN, beclin 1, LC3-I, and LC3-II in Ec109 and KYSE70 cells. Cellular lysates were analyzed by immunoblotting with respective first antibody followed by the second antibody. 

PTEN / PP2A / PHLPP1 ; 

PubMed: 22177954     


LNCaP and PC-3 cells were treated with CDDO-Me (0.3-5 µM) for 20 h and cell lysates were analyzed for PTEN, PP2A and PHLPP1 by immunoblotting. 

25897966 25733817 22177954
Immunofluorescence
PDI / SDHA ; 

PubMed: 26053096     


MDA-MB 435 cells were treated with or without 1.5 μM CDDO-Me for indicated time points. Immunocytochemistry using anti-PDI (red) and anti-SDHA (green) antibodies was performed and the representative fluorescence and phase contrast microscopic images of cells are shown. Scale bar: 20 μm.

c-PARP / Cytochrome C / COX IV; 

PubMed: 26053096     


E, F. MDA-MB 435 cells were untreated or treated with 1.5 μM CDDO-Me for 24 h. Immunocytochemistry of the cleaved PARP and staining with DAPI were performed (E). Immunocytochemistry of the cytochrome c (Cyt.c) and the subunit I of cytochrome c oxidase (COX IV) was performed (F) Representative fluorescence microscopic images of cells are shown. Scale bars: 50 μm.

26053096
Growth inhibition assay
Cell viability ; 

PubMed: 25733817     


(A) The chemical structure of CDDO-Me and (B) effects of CDDO-Me on the proliferation of Ec109, KYSE70, and Het-1A cells determined by the MTT assay. Notes: Cells were treated with CDDO-Me at 0.01, 0.05, 0.25, 1.0, and 5.0 μM for 24 or 48 hours. Data are the mean ± SD of at least four independent experiments.

25733817
体内研究

Bardoxolone Methyl(60 mg/kg)体内用药,可减少肺肿瘤的数量,大小和降低严重程度。 [4] Bardoxolone Methyl还可显著降低LPS刺激下的体内炎症因子的反应,诱导脾脏HO-1蛋白表达,对抗致死剂量的LPS保护小鼠。 [5]

推荐的实验操作(此推荐来自于公开的文献所以Selleck并不保证其有效性)

激酶实验:

[3]

- 合并

IKK 试验:

对IKK进行分析,以确定CDDO-ME对TNF诱导的IKK活化的效果。简言之,从全细胞提取物的IKK复合物与针对IKKα和IKKβ抗体沉淀,然后用蛋白A / G琼脂糖珠进行处理。 2小时后,用裂解缓冲液清洗珠粒,然后悬浮在含有50 mmol/L HEPES (pH 7.4) 的激酶测定混合物中,20 mmol/L MgCl2,2 mmol / L的DTT,2 mmol/L DTT, 20 μCi [γ-32P]ATP,10 μmol/L未标记的ATP和2 μg谷胱甘肽S-转移酶- IκBα(氨基酸1-54)的底物。在30℃下进行温育30分钟,然后加入SDS缓冲液,沸浴5分钟终止该反应。最后,该蛋白在10%SDS-PAGE凝胶中分离,干燥,用Storm820观察记录放射性条带。为了确定每个样品中的IKK-α和IKK-β的总量,将50 μg的全细胞蛋白在7.5%的SDS-PAGE下解析,电子转移至硝酸纤维素膜上,然后与抗-IKK-α或抗-IKK-β的抗体印迹杂交。
细胞实验:

[2]

- 合并
  • Cell lines: HL-60, KG-1, 和 NB4 细胞
  • Concentrations: ~5 μM
  • Incubation Time: 72 小时
  • Method:

    白血病细胞系以3.0 × 105 cells/mL的密度进行培养,同时白血病单核细胞以5 × 105 cells/mL的密度置于存在或不存在显示浓度的CDDO-ME中培养。加入适量的 DMSO(终浓度小于0.05%)作为对照。添加1 μM ara-C到培养基,用以细胞毒性研究。 24至72小时后,用血细胞计数板的台盼蓝染料排除法进行存活细胞计数。


    (Only for Reference)
动物实验:

[4]

- 合并
  • Animal Models: 雌性 A/J 小鼠 腹腔注射 Vinyl carbamate.
  • Dosages: ~60 mg/kg
  • Administration: 口服给药
    (Only for Reference)

溶解度 (25°C)

体外 DMSO 21 mg/mL (41.52 mM)
Water Insoluble
Ethanol Insoluble
体内 从左到右依次将纯溶剂加入产品,现配现用(数据来自Selleck实验检测而非文献):
4%DMSO+30% PEG300+5% Tween+61%ddH2O
2.5mg/mL

* 溶解度检测是由Selleck技术部门检测的,可能会和文献中提供的溶解度有所差异,这是由于生产工艺和批次不同产生的正常现象。请按照顺序依次加入各个纯溶剂。

化学数据

分子量 505.69
化学式

C32H43NO4

CAS号 218600-53-4
储存条件 粉状
溶于溶剂
别名 RTA 402, TP-155, NSC 713200, CDDO Methyl Ester, CDDO-Me

动物体内配方计算器 (澄清溶液)

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
给药剂量 mg/kg 动物平均体重 g 每只动物给药体积 ul 动物数量
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系Selleck为您提供正确的澄清溶液配方)
% DMSO % % Tween 80 % ddH2O
计算重置

计算器

摩尔浓度计算器

摩尔浓度计算器

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子量 (g/mol)

摩尔浓度计算公式

  • 质量
    浓度
    体积
    分子量

*在配置溶液时,请务必参考Selleck产品标签上、SDS / COA(可在Selleck的产品页面获得)批次特异的分子量使用本工具。

稀释计算器

稀释计算器

用本工具协助配置特定浓度的溶液,使用的计算公式为:

开始浓度 x 开始体积 = 最终浓度 x 最终体积

稀释公式

稀释公式一般简略地表示为: C1V1 = C2V2 ( 输入 输出 )

  • C1
    V1
    C2
    V2

在配置溶液时,请务必参考Selleck产品标签上、SDS / COA(可在Selleck的产品页面获得)批次特异的分子量使用本工具。.

连续稀释计算器方程

  • 连续稀释

  • 计算结果

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
分子量计算器

分子量计算器

通过输入化合物的化学式来计算其分子量:

总分子量:g/mol

注:化学分子式大小写敏感。C10H16N2O2 c10h16n2o2

摩尔浓度计算器

质量 浓度 体积 分子量
计算

临床试验信息

NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT02316821 Completed Drug: RTA 402|Drug: Placebo Chronic Kidney Disease|Type 2 Diabetes Kyowa Kirin Co. Ltd. December 2014 Phase 2
NCT02036970 Completed Drug: Bardoxolone methyl|Drug: Placebo Pulmonary Arterial Hypertension|Pulmonary Hypertension|Interstitial Lung Disease|Idiopathic Interstitial Pneumonia|Idiopathic Pulmonary Fibrosis|Sarcoidosis|Respiratory Bronchiolitis Associated Interstitial Lung Disease|Desquamative Interstitial Pneumonia|Cryptogenic Organizing Pneumonia|Acute Interstitial Pneumonitis|Idiopathic Lymphoid Interstitial Pneumonia|Idiopathic Pleuroparenchymal Fibroelastosis Reata Pharmaceuticals Inc. May 2014 Phase 2
NCT01598363 Completed Drug: Digoxin|Drug: Rosuvastatin Healthy Volunteers Reata Pharmaceuticals Inc. June 2012 Phase 1
NCT01551446 Withdrawn Drug: Bardoxolone Methyl Renal Insufficiency Chronic|Diabetes Mellitus Type 2 Reata Pharmaceuticals Inc. April 2012 Phase 1
NCT01503866 Completed Drug: bardoxolone methyl Healthy Reata Pharmaceuticals Inc. December 2011 Phase 1

技术支持

在订购、运输、储存和使用我们的产品的任何阶段,您遇到的任何问题,均可以通过拨打我们的热线电话400-668-6834,或者技术支持邮箱tech@selleck.cn,直接联系到我们。我们会在24小时内尽快联系您。

操作手册

如果有其他问题,请给我们留言。

  • * 必填项

IκB/IKK Signaling Pathway Map

相关IκB/IKK产品

Tags: 购买Bardoxolone Methyl | Bardoxolone Methyl供应商 | 采购Bardoxolone Methyl | Bardoxolone Methyl价格 | Bardoxolone Methyl生产 | 订购Bardoxolone Methyl | Bardoxolone Methyl代理商
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID